TMEM145 exhibits significantly high methylation status in all stages (I–III) of breast invasive ductal carcinoma, accompanied by upregulated gene expression, making it a potential epigenetic biomarker for breast cancer that may play a key role in cancer progression. The gene discussed is TMEM145; the disease is invasive ductal breast carcinoma.